CGON
CG Oncology, Inc. Common stock
NASDAQ: CGON · HEALTHCARE · BIOTECHNOLOGY
$64.75
-1.22% today
Updated 2026-04-29
Market cap
$5.70B
P/E ratio
—
P/S ratio
1,410.56x
EPS (TTM)
$-2.08
Dividend yield
—
52W range
$21 – $74
Volume
1.3M
CG Oncology, Inc. Common stock (CGON) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-2,097.00%
ROE
-21.70%
ROA
-15.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $10.36M | $-12.84M | 99.90% | -121.70% | -123.95% |
| 2022 | $191000.00 | $-35.44M | 92.15% | -18,453.40% | -18,556.54% |
| 2023 | $204000.00 | $-48.61M | 100.00% | -27,180.88% | -23,826.96% |
| 2024 | $1.14M | $-88.04M | 100.00% | -10,067.25% | -7,729.50% |
| 2025 | $4.04M | $-161.00M | -15.02% | -4,722.13% | -3,985.02% |